Monitor HeartBeam's progress toward the undisclosed performance milestones over the next year; achievement could trigger significant share issuance. The transaction bonus structure aligns Vajdic with a change-in-control event, but the redacted thresholds make it impossible to assess the likelihood. No immediate trading catalyst.
Price Chart
Executive Summary
HeartBeam granted President/Founder Branislav Vajdic a performance-based RSU award of 2,800,000 shares and a transaction bonus agreement tied to a change in control. The RSUs vest upon achieving operational, software, product-development, and clinical milestones within one year, plus three-year service-based vesting. The transaction bonus is contingent on a qualifying change in control and market capitalization thresholds (redacted). This is a routine compensatory arrangement, though the award size is significant relative to the company's $42M market cap.
Key Facts
- 2,800,000 performance-based RSUs granted to President/Founder Branislav Vajdic on June 15, 2026
- RSUs vest based on undisclosed operational, software, product-development, and clinical milestones within one year, plus one-third service vesting on each of the first three anniversaries
- Transaction bonus agreement provides for a bonus (1% + up to 1% additional of Aggregate Price Paid) upon a qualifying change in control, subject to market capitalization thresholds (redacted)
- Bonus is zero if minimum market cap threshold not met; bonus terminates if Vajdic ceases to be a service provider before a change in control
- Both awards are under the 2022 Equity Incentive Plan and include accelerated vesting provisions for qualifying termination or change in control
Financial Impact
No immediate cash impact; potential dilution of up to 2.8M shares if all RSUs vest, representing a substantial portion of outstanding shares (exact share count not disclosed). Transaction bonus amount is formulaic and contingent on change-in-control value.
Risk Factors
- Potential dilution of ~2.8M shares if all performance milestones are met and RSUs vest
- Failure to achieve milestones within one year results in forfeiture of unvested RSUs
- Transaction bonus may incentivize a sale at a price that benefits management over shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-070628 |
| Document: ea0295318-8k_heart.htm | 0001213900-26-070628 |
| Document: ea029531801ex10-1.htm | 0001213900-26-070628 |
| Document: 0001213900-26-070628-index-headers.html | 0001213900-26-070628 |
| Document: 0001213900-26-070628-index.html | 0001213900-26-070628 |
| Document: 0001213900-26-070628.txt | 0001213900-26-070628 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K / 424B5 | $0.5000 $0.4250 | ▲ +15.00% | ▲ +13.02% | $0.4090 (+18.20%) |
Aug 14, 2026 10w ago | 424B5 | $0.5000 $0.4250 | ▲ +15.00% | ▲ +13.02% | $0.4090 (+18.20%) |
Jun 22, 2026 18w ago | 8-K | $0.6863 $0.5684 | ▼ −17.18% | ▼ −18.34% | $0.4090 (−40.41%) |
Apr 16, 2026 27w ago | Insider Cluster | $0.8100 $1.01 | ▲ +24.69% | ▲ +18.88% | $0.4090 (−49.51%) |
Apr 16, 2026 27w ago | Insider Cluster | $0.8100 $1.01 | ▲ +24.69% | ▲ +18.88% | $0.4090 (−49.51%) |
Mar 18, 2026 31w ago | EFFECT | $1.26 $0.8100 | ▼ −35.71% | ▼ −41.76% | $0.4090 (−67.54%) |
Mar 13, 2026 32w ago | S-3/A | $1.27 $1.20 | ▲ +5.51% | ▲ +9.29% | $0.4090 (+67.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers